grace targeted therapies lung cancer 2021 - can a patient have multiple mutations & how to treat?
Published 2 years ago • 24 plays • Length 3:29Download video MP4
Download video MP3
Similar videos
-
3:09
grace targeted therapies lung cancer 2021 - best treatment patient with a designated kras mutation
-
2:08
grace targeted therapies lung cancer 2021 - approved therapy for a cdkn2a secondary mutation?
-
14:57
grace targeted therapies lung cancer 2021 - standards & novel therapies sensitizing mutations, pt 1
-
22:49
grace targeted therapies lung cancer 2021 - management of uncommon egfr mutations including exon 20
-
17:58
grace targeted therapies lung cancer 2021 - kras directed therapies: a new horizon
-
8:49
grace targeted therapies lung cancer 2021 - a role for chemo io in patients with egfr mutations?
-
21:33
optimal ngs platforms, how to interpret - grace targeted therapies in lung cancer patient forum 2021
-
21:58
grace targeted therapies lung cancer 2021 - alk therapies-which one comes first, how do we sequence?
-
3:35
grace targeted therapies lung cancer 2021 - recommended treatment for an alk variant 1 patient
-
14:05
grace targeted therapies lung cancer 2021 - standards & novel therapies sensitizing mutations, pt 2
-
14:33
grace targeted therapies lung cancer 2021 - targeted therapies in oligo-metastatic disease
-
16:03
grace targeted therapies lung cancer 2021 -the role of chemotherapy in driver positive patients
-
20:32
grace targeted therapies lung cancer 2021 - ros current therapies, emerging treatment options
-
8:46
grace targeted therapies in lung cancer 2021 - liquid and tissue biopsies in acquired resistance
-
17:53
grace targeted therapies lung cancer 2021 - genotype directed therapy: role in earlier stage disease
-
9:35
grace targeted therapies lung cancer 2021 - single agent immunotherapy if driver mutation positive?
-
7:27
intro and cancer 101 - grace targeted therapies in lung cancer patient forum 2021
-
2:24
grace targeted therapies lung cancer 2021 - what makes mutations vary?
-
22:44
grace targeted therapies lung cancer 2021 - new therapies: ntrk, ret and her2